Viridian partners with Kissei Pharmaceutical to advance thyroid eye disease therapies in Japan

Published on August 4, 2025
The partnership marks a major step toward expanding global access to targeted treatments for this vision-threatening condition, according to a news release.
Continue reading on website
Other news

Retinal microvasculature on OCTA may predict coronary artery disease risk

August 4, 2025
Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.

Novel Systemic Marker Identifies Diabetes Patients at High Risk of DR

August 5, 2025
A new study found that, compared with insulin resistance, parameters indicative of β-cell function—specifically, postprandial C-peptide to glucose ratio (PCGR)—were more closely related to DR independent of diabetes duration than HbA1c or other confounding factors. This chart from the study show the AUC curves for PCGR (red line) vs. HbA1c (blue line). Monitoring this systemic marker could help id